Literature DB >> 21548012

Sinonasal adenocarcinoma: a rare second malignancy in long term retinoblastoma survivors.

Pooja Bhagia1, Agnes Basas Colanta, David H Abramson, Diane L Carlson, Ruth A Kleinerman, Dennis Kraus, Ira J Dunkel.   

Abstract

Retinoblastoma is the most common primary cancer of the eye in children. The incidence of second tumors in survivors of bilateral retinoblastoma and in survivors of unilateral retinoblastoma who presumably carry a germline RB1 mutation is documented. This article describes the previously unrecognized association of sinonasal adenocarcinoma as a second malignancy in retinoblastoma survivors. We present three cases who received radiation therapy as a part of their treatment and developed sinonasal adenocarcinoma as a second malignancy. Sinonasal adenocarcinoma should be considered as a second malignancy in retinoblastoma survivors who present with vague sinus symptoms.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21548012      PMCID: PMC3867788          DOI: 10.1002/pbc.23161

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  18 in total

1.  Update on sinonasal adenocarcinoma: classification and advances in immunophenotype and molecular genetic make-up.

Authors:  Ilmo Leivo
Journal:  Head Neck Pathol       Date:  2007-11-28

2.  Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture.

Authors:  David H Abramson
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-08       Impact factor: 4.799

3.  Outcome of patients with a history of bilateral retinoblastoma treated for a second malignancy: the Memorial Sloan-Kettering experience.

Authors:  I J Dunkel; W L Gerald; N S Rosenfield; E W Strong; D H Abramson; F Ghavimi
Journal:  Med Pediatr Oncol       Date:  1998-01

Review 4.  Adenocarcinoma of the upper aerodigestive tract.

Authors:  Edward B Stelow; Stacey E Mills; Vickie Y Jo; Diane L Carlson
Journal:  Adv Anat Pathol       Date:  2010-07       Impact factor: 3.875

5.  Third (fourth and fifth) nonocular tumors in survivors of retinoblastoma.

Authors:  D H Abramson; M R Melson; I J Dunkel; C M Frank
Journal:  Ophthalmology       Date:  2001-10       Impact factor: 12.079

6.  Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk.

Authors:  F L Wong; J D Boice; D H Abramson; R E Tarone; R A Kleinerman; M Stovall; M B Goldman; J M Seddon; N Tarbell; J F Fraumeni; F P Li
Journal:  JAMA       Date:  1997-10-15       Impact factor: 56.272

Review 7.  Second nonocular tumors in survivors of heritable retinoblastoma and prior radiation therapy.

Authors:  B G Mohney; D M Robertson; P J Schomberg; D O Hodge
Journal:  Am J Ophthalmol       Date:  1998-08       Impact factor: 5.258

8.  Cause-specific mortality in long-term survivors of retinoblastoma.

Authors:  Chu-Ling Yu; Margaret A Tucker; David H Abramson; Kyoji Furukawa; Johanna M Seddon; Marilyn Stovall; Joseph F Fraumeni; Ruth A Kleinerman
Journal:  J Natl Cancer Inst       Date:  2009-04-07       Impact factor: 13.506

9.  Pediatric sinonasal neuroendocrine carcinoma after treatment of retinoblastoma.

Authors:  Alessandro Franchi; Iacopo Sardi; Valentina Cetica; Annamaria Buccoliero; Flavio Giordano; Federico Mussa; Lorenzo Genitori; Giuseppe Oliveri; Clelia Miracco
Journal:  Hum Pathol       Date:  2009-01-20       Impact factor: 3.466

Review 10.  Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.

Authors:  Anna T Meadows; Debra L Friedman; Joseph P Neglia; Ann C Mertens; Sarah S Donaldson; Marilyn Stovall; Sue Hammond; Yutaka Yasui; Peter D Inskip
Journal:  J Clin Oncol       Date:  2009-03-02       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.